Literature DB >> 16978736

An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings.

B Longo, A Pantosti, I Luzzi, P Placanica, S Gallo, A Tarasi, F Di Sora, M Monaco, A M Dionisi, I Volpe, F Montella, A Cassone, G Rezza.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16978736     DOI： 10.1016/j.jhin.2006.07.010

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  6 in total

1.  Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.

Authors:  Michele Iacono; Laura Villa; Daniela Fortini; Roberta Bordoni; Francesco Imperi; Raoul J P Bonnal; Thomas Sicheritz-Ponten; Gianluca De Bellis; Paolo Visca; Antonio Cassone; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

2.  Miltefosine Reduces the Cytolytic Activity and Virulence of Acinetobacter baumannii.

Authors:  Steven E Fiester; Brock A Arivett; Amber C Beckett; Benjamin R Wagner; Emily J Ohneck; Robert E Schmidt; Jennifer T Grier; Luis A Actis
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors.

Authors:  Hong-Yu Ou; Shan N Kuang; Xinyi He; Brenda M Molgora; Peter J Ewing; Zixin Deng; Melanie Osby; Wangxue Chen; H Howard Xu
Journal:  Sci Rep       Date:  2015-03-02       Impact factor: 4.379

4.  In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.

Authors:  Luigi Principe; Silvia D'Arezzo; Alessandro Capone; Nicola Petrosillo; Paolo Visca
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-05-21       Impact factor: 3.944

5.  In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.

Authors:  Maria Lina Mezzatesta; Giusi Trovato; Floriana Gona; Vito Mar Nicolosi; Daria Nicolosi; Alessandra Carattoli; Giovanni Fadda; Giuseppe Nicoletti; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-02-08       Impact factor: 3.944

Review 6.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.

Authors:  Uh Jin Kim; Hee Kyung Kim; Joon Hwan An; Soo Kyung Cho; Kyung-Hwa Park; Hee-Chang Jang
Journal:  Chonnam Med J       Date:  2014-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.